ID: ALA3586209

Max Phase: Preclinical

Molecular Formula: C18H16FN5O

Molecular Weight: 337.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1cnc(-c2ccc(C3CCC3)c(Oc3ncccn3)c2F)cn1

Standard InChI:  InChI=1S/C18H16FN5O/c19-16-13(14-9-24-15(20)10-23-14)6-5-12(11-3-1-4-11)17(16)25-18-21-7-2-8-22-18/h2,5-11H,1,3-4H2,(H2,20,24)

Standard InChI Key:  GKYUMEDTWYFCGN-UHFFFAOYSA-N

Associated Targets(Human)

Whole blood 398 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

5-lipoxygenase activating protein 3184 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 337.36Molecular Weight (Monoisotopic): 337.1339AlogP: 3.71#Rotatable Bonds: 4
Polar Surface Area: 86.81Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 1.85CX LogP: 2.96CX LogD: 2.96
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.78Np Likeness Score: -0.40

References

1. Pettersen D, Davidsson Ö, Whatling C..  (2015)  Recent advances for FLAP inhibitors.,  25  (13): [PMID:26004579] [10.1016/j.bmcl.2015.04.090]
2.  (2015)  Flap modulators, 
3. Gür ZT, Çalışkan B, Banoglu E..  (2018)  Drug discovery approaches targeting 5-lipoxygenase-activating protein (FLAP) for inhibition of cellular leukotriene biosynthesis.,  153  [PMID:28784429] [10.1016/j.ejmech.2017.07.019]